On August 23, 2024, Aion Therapeutic Inc., a company based in Toronto, Ontario, announced its plan to conduct a non-brokered private placement offering of up to 45,454,545 units at a price of $0.011 per unit, aiming to raise approximately $500,000 in total gross proceeds. Each unit will consist of one common share and one half of one common share purchase warrant. The warrant will be exercisable to acquire one share for a period of eighteen months after the closing of the offering, at an exercise price of $0.05 per warrant share.
The proceeds generated from the offering will be utilized for general working capital purposes, and all securities issued as part of the offering will be subject to a four-month hold period in accordance with applicable securities laws.
This announcement does not serve as an offer to sell or a solicitation to buy securities, and the securities offered have not been registered under the United States Securities Act of 1933. Aion Therapeutic Inc. is focused on driving innovation and transformative solutions in the health and wellness sector with a diverse portfolio of intellectual property. Through its subsidiary Toppen, the company aims to deliver cutting-edge water filtration solutions that are innovative, affordable, and sustainable.
For more information, please contact the company. This press release contains forward-looking information and readers are advised to exercise caution when relying on such information. The securities of the company have not been registered under the United States Securities Act of 1933. The Canadian Securities Exchange has not approved or disapproved of the contents of this press release. Distribution of this information to United States news wire services or dissemination in the United States is prohibited.
